Summary
CME Group Inc. (CME) filed a Form 8-K on August 11, 2026, primarily to disclose a change in its pricing structure communicated to clients through Special Executive Report No. 9799. While the specifics of the pricing adjustments are not detailed in this 8-K, the filing indicates that this information has been made available to clients and posted on the company's website. Investors should note that this filing is made under Regulation FD and is for disclosure purposes, not to trigger specific financial reporting requirements. The information provided is not deemed "filed" under the Securities Exchange Act of 1934, meaning it doesn't carry the same legal implications as other types of filings, and will not be incorporated by reference into other SEC filings unless explicitly stated.
Key Highlights
- 1CME Group Inc. announced pricing changes to its clients on August 11, 2026.
- 2The pricing adjustments were communicated via a Special Executive Report No. 9799.
- 3Details of the pricing changes are available to clients and have been posted on the CME Group website.
- 4The filing is made under Regulation FD, ensuring broad public disclosure.
- 5The information furnished is not considered 'filed' for purposes of Section 18 of the Exchange Act, limiting its liability implications.
- 6This filing does not alter CME Group's financial statements or existing exhibits, with the exception of the XBRL cover page.